Biologicals in psoriasis
JPAD-Journal of Pakistan Association of Dermatologists. 2008; 18 (2): 100-109
em Inglês
| IMEMR
| ID: emr-88421
ABSTRACT
During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Terapia Biológica
/
Proteínas Recombinantes de Fusão
/
Fator de Necrose Tumoral alfa
/
Receptores do Fator de Necrose Tumoral
/
Anticorpos Monoclonais
Idioma:
Inglês
Revista:
J. Pak. Assoc. Dermatol.
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS